跳转至内容
Merck
CN

Vitamin D and calcium receptors: links to hypercalciuria.

Current opinion in nephrology and hypertension (2006-06-16)
Shaochun Bai, Murray J Favus
摘要

In idiopathic hypercalciuria, patients have increased intestinal Ca absorption and decreased renal Ca reabsorption, with either elevated or normal serum levels of 1,25-dihydroxyvitamin D. As 1,25-dihydroxyvitamin D exerts its biologic effects through interactions with the vitamin D receptor, we examine the actions of this receptor and 1,25-dihydroxyvitamin D in animals with genetic hypercalciuria. In genetic hypercalciuric stone-forming rats intestinal calcium transport is increased and renal calcium reabsorption is reduced, yet serum 1,25-dihydroxyvitamin D levels are normal. Elevated intestinal and kidney vitamin D receptors suggest that increased tissue 1,25-dihydroxyvitamin D-vitamin D receptor complexes enhance 1,25-dihydroxyvitamin D actions on intestine and kidney, and vitamin D-dependent over-expression of renal calcium-sensing receptor alone can decrease tubule calcium reabsorption. In TRPV5-knockout mice, ablation of the renal calcium-influx channel decreases tubular calcium reabsorption, and secondary elevations in 1,25-dihydroxyvitamin D increase intestinal calcium transport. 1,25-Dihydroxyvitamin D or vitamin D receptor may change intestinal and renal epithelial calcium transport simultaneously or calcium-transport changes across renal epithelia may be primary with a vitamin D-mediated secondary increase in intestinal transport. The extent of homology between the animal models and human idiopathic hypercalciuria remains to be determined.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
麦角钙化醇, ≥98.0% (sum of enantiomers, HPLC)
Supelco
麦角钙化甾醇(维生素D2), Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
麦角钙化醇, 40,000,000 USP units/g
麦角钙化醇, European Pharmacopoeia (EP) Reference Standard